Paintings by Chagall, Russian 16th century icons to be on display at art fair in BrusselsSociety & Culture January 16, 21:50
Russia calls to probe into attack on Moscow Patriarchate’s church in Kiev — diplomatRussian Politics & Diplomacy January 16, 21:25
Russia, US start restoring business ties — ombudsmanBusiness & Economy January 16, 21:21
Figure skating pairs competition excluded from schedule of 2017 Winter UniversiadeSport January 16, 20:34
DPR top diplomat blames Kiev for dodging discussion of Steinmeier formula implementationWorld January 16, 20:14
IMF maintains forecast for global economy growth in 2017 at 3.4%Business & Economy January 16, 19:45
Six more settlements join Syria ceasefire regime — Defense MinistryWorld January 16, 19:22
Foreign Ministry: Washington initiating new arms race in EuropeRussian Politics & Diplomacy January 16, 19:15
Diplomat says anti-terror efforts must not be hostage to political ambitionsRussian Politics & Diplomacy January 16, 19:08
UNITED NATIONS, November 14. /TASS/. If the tests of experimental vaccines against the Ebola virus are successful, they will be available next year, UN Secretary-General’s special envoy David Nabarro said on Thursday. According to him, there are two highly promising potential vaccines. Sierra Leone’s Permanent Representative to the United Nations Vandi Chidi Minah told reporters that he expected “good news” about the results of the tests by the end of the current year.
According to the World Health Organization (WHO), the number of fatalities of the fever epidemic outbreak in West Africa has exceeded 5,100 people and 14,100 people have been infected. The situation is the most serious in Guinea, Liberia and Sierra Leone.
A number of countries are actively developing the Ebola vaccine. The UK, Japan, Russia and China have made progress in this area. On Wednesday, the international humanitarian organization Doctors Without Borders announced it would hold in December the vaccine testing in three medical centres in West Africa. Russia and China this week has allocated tens of millions of dollars for the development of the antiviral drugs.